Biotech Values

[davidal66]

I listened to the call just now and after the first peak they noted a robust increase in os or overall survival for TNFerade treated patients versus SOC at 22 months or so versus 10 months. I may have missed it, but did not hear what the overall survival numbers were. I'm glad I did not pull the trigger on GNVC. I loved the story, but this data set says the first peak was a fluke.